ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 84 filers reported holding ORIC PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $69,000 | -65.7% | 12,914 | -5.6% | 0.03% | -59.2% |
| Q4 2021 | $201,000 | -10.7% | 13,677 | +26.9% | 0.08% | -23.2% |
| Q3 2021 | $225,000 | +11.9% | 10,782 | -5.0% | 0.10% | +19.3% |
| Q2 2021 | $201,000 | -2.4% | 11,349 | +35.2% | 0.08% | -4.6% |
| Q1 2021 | $206,000 | -26.2% | 8,394 | +1.8% | 0.09% | -25.0% |
| Q4 2020 | $279,000 | – | 8,247 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 4,768,181 | $99,703,000 | 11.34% |
| Euclidean Capital LLC | 777,193 | $16,251,000 | 7.90% |
| Memorial Sloan Kettering Cancer Center | 602,272 | $12,594,000 | 7.85% |
| Invus Financial Advisors, LLC | 1,007,575 | $21,068,000 | 5.64% |
| EcoR1 Capital, LLC | 3,468,944 | $72,536,000 | 2.52% |
| EMERALD ADVISERS, LLC | 726,236 | $15,186,000 | 0.55% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 742,666 | $15,529,000 | 0.54% |
| Orbimed Advisors | 2,337,574 | $48,879,000 | 0.54% |
| Casdin Capital, LLC | 601,515 | $12,578,000 | 0.31% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 53,000 | $1,104,000 | 0.27% |